noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

National Nurses United

UCI Health Irvine nurses to hold rally protesting unsafe staffing,[...]
George Mason University

George Mason University and VCU partnership seeks answers to chronic[...]
Netflix Inc.

A Decade Built with Korean Creators: Netflix Marks 10 Years in Korea

Healthcare

Xencor Inc.

10/25/2026 | Press release | Distributed by Public on 10/25/2026 02:45

Xencor Presents Phase 1 Dose Selection Data for XmAb819, a Potential First-in-Class ENPP3 x CD3 Bispecific T-Cell Engager, in Development for Patients With Advanced Clear Cell[...]

Read this content

Click here to read the original version at the source's official website. The text of this article is not available at the moment.

Xencor Inc. published this content on October 25, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on October 25, 2026 at 08:45 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]